Skip to main content
Figure 2 | Journal of Ovarian Research

Figure 2

From: Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)

Figure 2

Kaplan-Meier plots and multivariate Cox-Regression analysis in EOC patients. Comparison of overall survival of Her-2 positive vs. negative cases (D) revealed no significant difference. However in FSHR negative cases (A) Her-2 positivity was strongly associated with shortened overall survival (p = 0.001) and turned out to be an independent prognosticator (B) in these patients. No link of Her-2 expression and prognosis could be observed in FSHR positive patients (C).

Back to article page